[1]
2016. ROLE OF HORMONE RECEPTORS AND HER2 IMMUNOHISTOCHEMISTRY IN PREDICTING RESPONSE TONEOADJUVANT CHEMOTHERAPY IN BREAST CANCER. INTERNATIONAL JOURNAL OF ADVANCED RESEARCH AND REVIEW (IJARR). 1, 11 (Nov. 2016), 22–26.